Full video transcriptClick to expand
Auto-generated transcript of @robertmalagisi's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Alright, so if you're an entrepreneur, if you're in the online money space, I'm about to put you on fucking game
- 0:04If you are already taking peptides or if you're not taking peptides
- 0:07And when I tell you this shit's a cheap code
- 0:09Just know it's a fucking cheap code
- 0:11These are gonna be your two best friends, C-Max and Selenk
- 0:14Literally easy as just squirting the shit up your nostril
- 0:17If you're already taking C-Max or Selenk, you already know this shit is crazy
- 0:21Everybody needs it, I promise you, if you think peptides are shit or you think you don't need it at all
- 0:25It's literally missing out on money, bro
- 0:27And just to top it off, you need a Celsius down the hatch
- 0:30And if you want to get a little jiggy with it, toss a little bit of adder
- 0:33Probably looking at me crazier now but combine all the four
- 0:36And just let me know how crazy your work they were
- 0:38Not gonna tell you where to get them, just do your own research, it's super easy to find them
- 0:42But just know you're gonna be so fucking dialed, bro
- 0:44If you really want to be dialed, pop it off for the grand five
- 0:47Right down the hatch
@robertmalagisi's peptide money claims, fact-checked
Quick answer
Semax and selank are synthetic peptides studied primarily in Russian clinical literature for neuroprotection and anxiety reduction respectively, with limited large-scale human trial data in healthy adults. Neither is FDA-approved, and their combination with Adderall, a Schedule II amphetamine, has no safety or efficacy data and carries real cardiovascular and psychiatric risk. The intranasal delivery method the creator describes is consistent with research administration routes, but that accuracy does not validate the broader stack or the productivity claims.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @robertmalagisi's peptide money claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@robertmalagisi's peptide money claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "@robertmalagisi's peptide money claims, fact-checked" from robertmalagisi. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semax and selank are synthetic peptides studied primarily in Russian clinical literature for neuroprotection and anxiety reduction respectively, with limited large-scale human trial data in healthy adults.
The reason this review is not generic is the source wording and the canonical claim label "peptides ts is actually a irl money cheat code." In this clip, the useful excerpt is: "Alright, so if you're an entrepreneur, if you're in the online money space, I'm about to put you on fucking game If you are already taking peptides or if you're not taking peptides And when I tell you this shit's a cheap code Just know..." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Semax and selank are synthetic peptides studied primarily in Russian clinical literature for neuroprotection and anxiety reduction respectively, with limited large-scale human trial data in healthy adults.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax and selank are synthetic peptides studied primarily in Russian clinical literature for neuroprotection and anxiety reduction respectively, with limited large-scale human trial data in healthy adults. Neither is FDA-approved, and their combination with Adderall, a Schedule II amphetamine, has no safety or efficacy data and carries real cardiovascular and psychiatric risk. The intranasal delivery method the creator describes is consistent with research administration routes, but that accuracy does not validate the broader stack or the productivity claims.
- Semax has legitimate early neuroscience data: Dolotov et al. (2006) found BDNF modulation in animal models, but human productivity trials in healthy adults do not exist.
- Selank's most replicated finding is anxiolytic effect, not cognitive enhancement. Zozulya et al. (2014, Drugs in R&D) showed anxiety reduction comparable to some benzodiazepines, which is not the same as a business performance upgrade.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax has legitimate early neuroscience data: Dolotov et al. (2006) found BDNF modulation in animal models, but human productivity trials in healthy adults do not exist.
- Selank's most replicated finding is anxiolytic effect, not cognitive enhancement. Zozulya et al. (2014, Drugs in R&D) showed anxiety reduction comparable to some benzodiazepines, which is not the same as a business performance upgrade.
- Adderall is a Schedule II controlled substance in the United States. Recommending it as a casual stack addition to 271,000 people without prescription context is not optimization content, it is a liability the viewer bears alone.
- No published research examines the four-way semax-selank-caffeine-amphetamine combination this video describes. Stacking stimulants increases cardiovascular load and psychiatric risk with no studied synergistic benefit.
- Intranasal delivery of semax and selank is consistent with research protocols, but that accuracy does not validate self-directed sourcing from unregulated suppliers where purity and concentration are unverified.
- Neither semax nor selank is FDA-approved. Both are sold in gray-market research contexts, and any telehealth provider prescribing them should conduct full intake and contraindication screening before doing so.
- Moran et al. (2019, Journal of Clinical Psychiatry) found significant rates of adverse events including cardiovascular and psychiatric effects in young adults misusing prescription stimulants, a risk this video does not acknowledge.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @robertmalagisi actually say?
The creator pitched semax and selank as cognitive "cheat codes" for entrepreneurs, describing them as easy intranasal sprays that will get you "so fucking dialed." Then he escalated: add a Celsius energy drink, throw in some Adderall, and you have a four-way stack he calls the path to elite productivity. He never named a dose, a source, or a single study. He closed by suggesting viewers just "do your own research" to find these compounds.
To be direct: this is a hype reel, not health information. Two of the four substances he mentioned (semax and selank) are research peptides with genuinely interesting early data. One (Celsius) is just a caffeinated drink. And one, Adderall, is a Schedule II controlled substance. Lumping all four together as a casual productivity stack is where this goes from enthusiastic to actually risky.
Does the science back this up?
Semax and selank have real, if early-stage, research behind them, primarily from Russian and Eastern European clinical literature. The "cheat code" framing is not what the studies show, but dismissing the compounds entirely would also be inaccurate.
Semax is a synthetic analogue of ACTH(4-7) that has been studied for neuroprotection and cognitive effects. Dolotov et al. (2006, Journal of Molecular Neuroscience) found it modulates brain-derived neurotrophic factor expression in rodent models, which is relevant to learning and memory. Human data is thin and mostly from Russian-language studies on stroke recovery, not healthy entrepreneur optimization.
Selank is a synthetic analogue of tuftsin with anxiolytic properties studied in Russia. Zozulya et al. (2014, Drugs in R&D) found it reduced anxiety comparably to benzodiazepines in some measures without sedation in a clinical sample. That is interesting. It is not a productivity drug, though. It is closer to an anti-anxiety compound, which could indirectly help focus if anxiety is the limiting factor.
Neither compound has been approved by the FDA. Neither has large-scale randomized controlled trial data in healthy adults chasing business productivity.
What did they get wrong (or right)?
Credit where it is due: semax and selank are not pseudoscience. They have more legitimate research behind them than most peptides discussed on TikTok. The intranasal delivery route he mentions is also consistent with how these compounds are typically administered in the literature, since intranasal delivery can bypass the blood-brain barrier more efficiently than oral routes for certain peptides.
But the stack recommendation is a serious problem. Casually suggesting viewers add Adderall to a semax-selank-caffeine combination is not optimization advice. It is a recipe for cardiovascular strain and potential psychiatric risk. Adderall is amphetamine. Combining stimulants, even legal ones, increases heart rate, blood pressure, and the risk of anxiety, psychosis triggers, and dependency. There is no published literature studying this specific four-way combination. The creator offers zero dosing guidance, zero contraindication warnings, and zero acknowledgment that Adderall requires a prescription for a reason.
Saying "just do your own research" when recommending a Schedule II controlled substance to 271,000 viewers is not responsible content creation. That framing shifts liability while the risk stays with the viewer.
What should you actually know?
If semax or selank genuinely interest you, the honest picture is this: the early data is intriguing enough that researchers are still studying them. They are not approved medications in the United States. Compounded versions are available through some telehealth platforms, but quality control varies significantly and you should only use them under medical supervision with a provider who has actually read the literature.
The anxiolytic effects of selank are probably the most reproducible finding across the available studies. If chronic stress or anxiety is blunting your focus, there is a plausible mechanism there. Semax as a nootropic for healthy adults is much less supported than its neuroprotective data in acute injury models.
The Adderall recommendation in this video should be ignored entirely if you do not have a legitimate ADHD diagnosis and prescription. Stimulant misuse for productivity is well-documented as a path toward tolerance, withdrawal, sleep disruption, and in some cases, more serious cardiovascular and psychiatric events. Moran et al. (2019, Journal of Clinical Psychiatry) documented significant rates of misuse-related adverse events in young adults. No peptide stack changes that risk profile.
The bottom line on regulatory and safety status
Semax and selank are not FDA-approved. They are not legal to market as drugs in the United States. MK-677 is also referenced in the video's category context and remains similarly unapproved. Adderall is a Schedule II controlled substance. A telehealth provider who recommends this stack as described in this video without a full intake, contraindication screening, and legitimate ADHD evaluation is not practicing responsibly. A TikTok creator who does it in 60 seconds is doing something worse.
- Semax: research compound, not FDA-approved, some legitimate neuroscience data
- Selank: research compound, not FDA-approved, anxiolytic data is its strongest finding
- Celsius: caffeinated energy drink, no meaningful therapeutic effect beyond caffeine
- Adderall: Schedule II controlled substance, illegal without a prescription, real cardiovascular and psychiatric risks when misused
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
robertmalagisi · TikTok creator
271.4K views on this video
ts is actually a IRL money cheat code 😭🙏
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about semax has legitimate early neuroscience data: dolotov et al. (2006)?
Semax has legitimate early neuroscience data: Dolotov et al. (2006) found BDNF modulation in animal models, but human productivity trials in healthy adults do not exist.
What does the video say about selank's most replicated finding?
Selank's most replicated finding is anxiolytic effect, not cognitive enhancement. Zozulya et al. (2014, Drugs in R&D) showed anxiety reduction comparable to some benzodiazepines, which is not the same as a business performance upgrade.
What does the video say about adderall?
Adderall is a Schedule II controlled substance in the United States. Recommending it as a casual stack addition to 271,000 people without prescription context is not optimization content, it is a liability the viewer bears alone.
What does the video say about no published research examines the four-way semax-selank-caffeine-amphetamine combination this video?
No published research examines the four-way semax-selank-caffeine-amphetamine combination this video describes. Stacking stimulants increases cardiovascular load and psychiatric risk with no studied synergistic benefit.
What does the video say about intranasal delivery of semax?
Intranasal delivery of semax and selank is consistent with research protocols, but that accuracy does not validate self-directed sourcing from unregulated suppliers where purity and concentration are unverified.
What does the video say about neither semax nor selank?
Neither semax nor selank is FDA-approved. Both are sold in gray-market research contexts, and any telehealth provider prescribing them should conduct full intake and contraindication screening before doing so.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by robertmalagisi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.